Vistagen Therapeutics (VTGN) Common Equity (2009 - 2026)
Vistagen Therapeutics' Common Equity came in at $14.99 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 77.4% from $66.34 million a year earlier and down 38.8% from the prior quarter.
Vistagen Therapeutics (VTGN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Common Equity was $35.52 million, down 49.5% from FY2025.
- Common Equity carries a five-year compound annual growth rate of -17.3% (FY2021 to FY2026).
- Going back by fiscal year, Common Equity was $70.39 million in FY2025 (-38.4%), $114.29 million in FY2024 (+846.1%), $12.08 million in FY2023 (-81.3%) and $64.72 million in FY2022 (-29.6%).
- The fiscal Q2 2027 figure represents the lowest quarterly Common Equity since fiscal Q1 2024.
- Year-over-year, Common Equity has declined for eight consecutive quarters, with an average decline of 46.0% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2024 (growth of 846.1%), and the weakest in fiscal Q1 2024 (a decline of 85.1%).
- Business Quant data shows VTGN's Common Equity at $24.48 million (Q1 2027), $35.52 million (Q4 2026) and $50.92 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -159,093.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 40.27 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 81.53 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | -4.58 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 44.95 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | 24.30 Bn |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | 14.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.99 Mn |
| Jun 30, 2026 | 24.48 Mn |
| Mar 31, 2026 | 35.52 Mn |
| Dec 31, 2025 | 50.92 Mn |
| Sep 30, 2025 | 66.34 Mn |
| Jun 30, 2025 | 56.77 Mn |
| Mar 31, 2025 | 70.39 Mn |
| Dec 31, 2024 | 81.12 Mn |
| Sep 30, 2024 | 92.97 Mn |
| Jun 30, 2024 | 104.80 Mn |
| Mar 31, 2024 | 114.29 Mn |
| Dec 31, 2023 | 123.29 Mn |
| Sep 30, 2023 | 35.65 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Mar 31, 2023 | 12.08 Mn |
| Dec 31, 2022 | 20.67 Mn |
| Sep 30, 2022 | 29.61 Mn |
| Jun 30, 2022 | 46.05 Mn |
| Mar 31, 2022 | 64.72 Mn |
| Dec 31, 2021 | 79.98 Mn |
Vistagen Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();